Vildagliptin decreases postprandial chylomicron triglycerides (TGs) in drug-naive patients with type 2 diabetes (T2DM)

被引：0
|
作者：
Matikainen, Niina
Manttari, Sakari
Schweizer, Anja
Ulvestad, Anne
Mills, David
Dunning, Beth E.
Foley, James E.
Taskinen, Marja-Riitta
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A125 / A125
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes (T2DM) and mild hyperglycemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    [J]. DIABETES, 2007, 56 : A134 - A134
  • [2] Efficacy of vildagliptin in drug-naive patients with type 2 diabetes
    Dejager, S.
    Baron, M. A.
    Razac, S.
    Foley, J. E.
    Dickinson, S.
    Schweizer, A.
    [J]. DIABETOLOGIA, 2006, 49 : 479 - 480
  • [3] Empagliflozin Monotherapy Improves Glucose Control in Drug-Naive Patients With Type 2 Diabetes (T2DM)
    Roden, Michael
    Weng, Jianping
    Eilbracht, Jens
    Delafont, Bruno
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A280 - A280
  • [4] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2014, 63 : A69 - A69
  • [5] Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naive Patients with Type 2 Diabetes (T2DM)
    Roden, Michael W.
    Weng, Jianping
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [6] Vildagliptin is as effective as rosiglitazone in lowering HbA1c but without weight gain in drug-naive patients with type 2 diabetes (T2DM)
    Rosenstock, Julio
    Baron, Michelle A.
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    [J]. DIABETES, 2006, 55 : A133 - A133
  • [7] Restoration of an acute insulin response to glucose (AIRg) in drug-naive patients with type diabetes (T2DM) by 3-month treatment with vildagliptin
    D'Alessio, David A.
    Watson, Catherine E.
    He, Yan-Ling
    Ligueros-Saylan, Monica
    Wang, Yibin
    Dunning, Beth E.
    Prigeon, Ronald L.
    Foley, James E.
    Pratley, Richard E.
    [J]. DIABETES, 2006, 55 : A108 - A108
  • [8] Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes
    Pi-Sunyer, F. Xavier
    Schweizer, Anja
    Mills, David
    Dejager, Sylvie
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 132 - 138
  • [9] Vildagliptin as add-on to insulin in patients with type 2 diabetes (T2DM)
    Fonseca, Vivian
    Dejager, Sylvie
    Albrecht, Diego
    Shirt, Lynda
    Schweizer, Anja
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [10] Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
    Scherbaum, W. A.
    Schweizer, A.
    Mari, A.
    Nilsson, P. M.
    Lalanne, G.
    Jauffret, S.
    Foley, J. E.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 675 - 682
12345